AQR Capital Management - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 207 filers reported holding DENALI THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$240,949
+13.7%
8,165
-11.3%
0.00%
Q1 2023$211,991
-71.0%
9,201
-59.4%
0.00%
-100.0%
Q1 2022$730,000
-68.3%
22,686
-56.1%
0.00%
-75.0%
Q4 2021$2,304,000
-44.3%
51,667
-37.0%
0.00%
-50.0%
Q3 2021$4,139,000
-33.4%
82,049
+3.5%
0.01%
-27.3%
Q2 2021$6,219,000
+25.7%
79,284
-8.5%
0.01%
+37.5%
Q1 2021$4,946,000
-7.5%
86,624
+35.6%
0.01%
-11.1%
Q4 2020$5,349,000
+191.3%
63,867
+24.6%
0.01%
+200.0%
Q3 2020$1,836,000
+163.0%
51,247
+77.5%
0.00%
+200.0%
Q2 2020$698,000
+48.5%
28,877
+7.6%
0.00%0.0%
Q1 2020$470,000
-45.2%
26,830
-45.5%
0.00%0.0%
Q4 2019$857,000
-18.9%
49,205
-28.7%
0.00%0.0%
Q3 2019$1,057,000
+391.6%
68,994
+566.9%
0.00%
Q2 2019$215,00010,3460.00%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Crestline Management, LP 7,705,039$343,645,00025.68%
Casdin Capital, LLC 1,500,000$66,900,0001.89%
Flagship Pioneering Inc. 2,619,968$116,851,0001.81%
SECTORAL ASSET MANAGEMENT INC 189,600$8,456,0001.27%
Integral Health Asset Management, LLC 100,000$4,460,0001.23%
Temasek Holdings (Private) Ltd 5,369,487$239,479,0000.86%
Goldstream Capital Management Ltd 78,418$3,497,0000.86%
Yiheng Capital Management, L.P. 335,184$14,949,0000.76%
GILDER GAGNON HOWE & CO LLC 2,900,114$129,345,0000.74%
Artal Group S.A. 600,000$26,760,0000.73%
View complete list of DENALI THERAPEUTICS INC shareholders